Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Registry of Toxic Effects of Chemical Substances (RTECS)

Nitroglycerin

RTECS #

QX2100000

CAS #

55-63-0

Updated

June 2017

Molecular Weight

227.11

Molecular Formula

C3H5N3O9

Synonyms

1,2,3-Propanetriol, trinitrate (9CI)
1,2,3-Propanetriyl nitrate
Angibid
Anginine
Angiolingual
Angorin
Blasting gelatin
Blasting oil
Cardamist
Gilucor nitro
Glonoin
Glycerintrinitrate (Czech)
Glycerol trinitrate
Glycerol(trinitrate de) (French)
Glycerol, nitric acid triester
Glyceroltrinitraat (Dutch)
Glyceryl nitrate
Glyceryl trinitrate
GTN
Klavikordal
Lenitral
Myocon
Myoglycerin
NG
Niglin
Niglycon
Niong
Nitora
Nitric acid triester of glycerol
Nitrin
Nitrine
Nitrine-TDC
Nitro-dur
Nitroglicerina (Italian)
Nitrogliceryna (Polish)
Nitroglycerin (ACGIH:OSHA)
Nitroglycerin, spirits of
Nitroglycerin-ACC
Nitroglycerine
Nitroglycerol
Nitroglyn
Nitrolan
Nitro-lent
Nitroletten
Nitrolingual
Nitrolowe
Nitromel
Nitronet
Nitrong
Nitrorectal
Nitro-span
Nitrostabilin
Nitrostat
Nitrozell retard
NK-843
NTG
Nysconitrine
Perglottal
Propanetriol trinitrate
RCRA waste number P081
S.N.G
SK-106N
Solution glyceryl trinitrate
Soup
Spirit of glonoin
Spirit of glyceryl trinitrate
Spirit of trinitroglycerin
Temponitrin
TNG
Trinalgon
Trinitrin
Trinitroglycerin
Trinitroglycerol
Trinitrol
Vasoglyn

Skin and Eye Irritation and References

Route/OrganismDoseEffectReference
eye /rabbit 0.1 mLHPV319 -,-,2002
skin /rabbit 500 mg/24H mildNTIS** AD-B011-150
skin /rabbit 0.5 mL mildHPV319 -,-,2002

Mutation Data and Reference

System TestRoute/Organism/TissueDoseReference
DNA inhibitionmammary gland/cattle30 µmol/L/24HMOCAE8 59,1044,2001
mutation in mammalian somatic cellsother cell types/human800 µmol/L/24HEMMUEG 38,261,2001
mutation in mammalian somatic cellsintraperitoneal/mouse5 mg/kgJJIND8 92,1429,2000
mutation in microorganisms/Salmonella typhimurium2500 nmol/plate (+enzymatic activation step)MUREAV 298,187,1993
mutation in microorganisms/Salmonella typhimurium50 µg/well (-enzymatic activation step)CBINA8 19,77,1977
mutation in microorganisms/Salmonella typhimurium1000 µg/plate (-enzymatic activation step)HPV319 -,-,2002
mutation in microorganisms/Salmonella typhimurium1000 µg/plate (+enzymatic activation step)HPV319 -,-,2002
specific locus testother cell types/human800 µmol/L/24HEMMUEG 38,261,2001
specific locus testintraperitoneal/mouse5 mg/kgJJIND8 92,1429,2000

Reproductive Effects Data and References

Route/OrganismDoseEffectReference
intraperitoneal/rat 11 mg/kg (7-17D pregnant)Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)

Reproductive: Effects on embryo or fetus: Fetal death
YACHDS 13,3807,1985
intraperitoneal/rat 220 mg/kg (7-17D pregnant)Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord)

Reproductive: Specific developmental abnormalities: Musculoskeletal system
YACHDS 13,3807,1985
intraperitoneal/rat 2580 mg/kg (91D male/2W pre-7D pregnant)Reproductive: Maternal effects: Menstrual cycle changes or disorders

Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)

Reproductive: Other effects to embryo or fetus
YACHDS 13,3783,1985
intraperitoneal/rat 520 mg/kg (17D preg-20D after birth)Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)YACHDS 13,3843,1985
oral/rat 73440 mg/kg (multigeneration)Reproductive: Other effects on male

Reproductive: Other effects on female

Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
HPV319 -,-,2002
skin/rat 3640 mg/kg (17-21D preg/21D after birth)Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)

Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
KSRNAM 18,3564,1984

Tumorigenic Data and References

Route/OrganismDoseEffectReference
oral/rat lowest published toxic dose: 36500 mg/kg/2Y- continuousTumorigenic: Equivocal tumorigenic agent by RTECS criteria

Liver: Tumors
ATSUDG 4,88,1980
oral/rat toxic dose: 438 gm/kg/2Y- continuousTumorigenic: Equivocal tumorigenic agent by RTECS criteria

Liver: Tumors

Reproductive: Tumorigenic effects: Testicular tumors
ATSUDG 4,88,1980
oral/rat lowest published toxic dose: 161330 mg/kg/2Y- intermittentTumorigenic: Equivocal tumorigenic agent by RTECS criteria

Liver: Tumors

Tumorigenic: Increased incidence of tumors in susceptible strains
HPV319 -,-,2002
oral/rat lowest published toxic dose: 240170 mg/kg/2Y- intermittentTumorigenic: Equivocal tumorigenic agent by RTECS criteria

Liver: Tumors

Tumorigenic: Increased incidence of tumors in susceptible strains
HPV319 -,-,2002

Acute Toxicity Data and References

Route/OrganismDoseEffectReference
In Vitro/pzxInhibitor Concentration (50 percent kill): 26.9 nmol/LVascular: Relaxation (isolated tissue)TXAPA9 256,95,2011
intraarterial/Dog lowest published toxic dose: 1000 ng/kgVascular: Measurement of regional blood flow

Blood: Changes in spleen
CEXPB9 33,81,2006
intraperitoneal/mouse lethal dose (50 percent kill): 104 mg/kgBehavioral: Ataxia

Lung, Thorax, or Respiration: Dyspnea

Nutritional and Gross Metabolic: Body temperature decrease
IYKEDH 13,90,1982
intraperitoneal/rabbit lethal dose (50 percent kill): 189 mg/kgNIIRDN -,786,1990
intraperitoneal/rat lethal dose (50 percent kill): 102 mg/kgBehavioral: Ataxia

Lung, Thorax, or Respiration: Dyspnea

Nutritional and Gross Metabolic: Body temperature decrease
IYKEDH 13,90,1982
intraperitoneal/rat lowest published toxic dose: 10 mg/kgBehavioral: AnalgesiaEJPHAZ 464,159,2003
intravenous/cat lowest published toxic dose: 0.5 mg/kgCardiac: Change in force of contraction

Cardiac: Pulse rate increased without fall in BP

Vascular: BP lowering not characterized in autonomic section
FATOAO 44,174,1981
intravenous/cat lowest published toxic dose: 1 mg/kgCardiac: Other changes

Vascular: BP lowering not characterized in autonomic section

Vascular: Measurement of regional blood flow
FATOAO 47,55,1984
intravenous/cat lowest published lethal dose: 5 mg/kgCardiac: Change in conduction velocity

Vascular: BP lowering not characterized in autonomic section
FATOAO 47,55,1984
intravenous/Dog lethal dose (50 percent kill): 19 mg/kgEye: Hemorrhage

Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Dyspnea
OYYAA2 22,629,1981
intravenous/man lowest published toxic dose: 51429 µg/kg/2D- intermittentBrain and Coverings: Encephalitis

Eye: Miosis (pupilliary constriction)

Eye: Corneal damage
AIMEAS 101,500,1984
intravenous/man lowest published toxic dose: 7.14 ng/kgVascular: Regional or general arteriolar or venous dilationCLPTAT 67,22,2000
intravenous/mouse lethal dose (50 percent kill): 30 mg/kgFATOAO 47,55,1984
intravenous/mouse lethal dose (50 percent kill): 10600 µg/kgBehavioral: Ataxia

Lung, Thorax, or Respiration: Dyspnea

Nutritional and Gross Metabolic: Body temperature decrease
IYKEDH 13,90,1982
intravenous/rabbit lethal dose (50 percent kill): 45 mg/kgNIIRDN 6,547,1982
intravenous/rabbit lowest published toxic dose: 340 µg/kgCardiac: Change in rate

Vascular: BP lowering not characterized in autonomic section
CEXPB9 30,812,2003
intravenous/rabbit lethal dose (50 percent kill): 45 mg/kgBehavioral: Convulsions or effect on seizure threshold

Cardiac: Change in rate

Gastrointestinal: Changes in structure or function of salivary glands
HPV319 -,-,2002
intravenous/rat lowest published toxic dose: 8 µg/kgVascular: BP lowering not characterized in autonomic sectionBIPBU* 24,1370,2001
intravenous/rat lowest published toxic dose: 60 µg/kgBrain and Coverings: Other degenerative changes

Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
JOETD7 136,267,2011
intravenous/rat lowest published toxic dose: 1714.3 µg/kg/1HBehavioral: ToleranceAAPSP* 4,10,2002
intravenous/rat lethal dose (50 percent kill): 23200 µg/kgBehavioral: Somnolence (general depressed activity)

Behavioral: Tremor

Behavioral: Ataxia
JJATDK 3,161,1983
intravenous/woman lowest published toxic dose: 48 µg/kgBehavioral: Headache

Vascular: BP lowering not characterized in autonomic section

Reproductive: Maternal effects: Uterus, cervix, vagina
FCLPH* 18,207,2004
intravenous/woman lowest published toxic dose: 3.77 µg/kg/60MBehavioral: Headache

Cardiac: Pulse rate decreased with fall in BP

Vascular: BP lowering not characterized in autonomic section
CEXPB9 35,580,2008
oral/guinea pig lethal dose (50 percent kill): 1450 mg/kgCardiac: Other changes

Lung, Thorax, or Respiration: Cyanosis

Blood: Methemoglobinemia- Carboxhemoglobinemia
STGNBT -,180,1999
oral/human lowest published toxic dose: 0.0083 mg/kgCardiac: Change in rate

Vascular: Measurement of regional blood flow
FATOAO 49,84,1986
oral/human lowest published toxic dose: 0.004 mg/kgCardiac: Change in rate

Cardiac: Cardiac output

Vascular: Other changes
BCLPT* 102(Suppl 1),50,2008
oral/human lowest published toxic dose: 0.004 mg/kgVascular: Other changesBCLPT* 102(Suppl 1),50,2008
oral/mammal (species unspecified) lethal dose (50 percent kill): 105 mg/kgTOVEFN (1),14,2001
oral/mouse lethal dose (50 percent kill): 1055 mg/kgBehavioral: Ataxia

Lung, Thorax, or Respiration: Respiratory depression
HPV319 -,-,2002
oral/mouse lethal dose (50 percent kill): 115 mg/kgBehavioral: Somnolence (general depressed activity)YACHDS 13,3649,1985
oral/rabbit lethal dose (50 percent kill): 1607 mg/kgNIIRDN -,786,1990
oral/rat lethal dose (50 percent kill): 105 mg/kgBehavioral: Somnolence (general depressed activity)YACHDS 13,3649,1985
oral/rat lowest published toxic dose: 1360 mg/kgBrain and Coverings: Other degenerative changes

Behavioral: Tetany

Cardiac: Cardiomyopathy including infarction
FATOAO 48,76,1985
oral/rat lowest published toxic dose: 10 mg/kgVascular: Measurement of regional blood flow

Gastrointestinal: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
JPHPH* 59,103,2008
oral/rat lowest published toxic dose: 10 mg/kgBiochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases

Biochemical: Metabolism (intermediary): Lipids including transport
JPHPH* 59,103,2008
oral/rat lethal dose (50 percent kill): 685 mg/kgGastrointestinal: Other changesHPV319 -,-,2002
oral/woman lowest published toxic dose: 5 mg/kgBehavioral: General anesthetic

Cardiac: Other changes

Kidney, Ureter, and Bladder: Incontinence
NAYXEW 8,181,1988
oral/woman lowest published toxic dose: 8 µg/kgBehavioral: Headache

Cardiac: Pulse rate decreased with fall in BP

Gastrointestinal: Nausea or vomiting
AJEMEN 11,253,1993
oral/woman lowest published toxic dose: 8 µg/kgCardiac: Pulse rate decreased with fall in BP

Vascular: BP lowering not characterized in autonomic section

Lung, Thorax, or Respiration: Other changes
AEMED3 23,31,1994
skin/mouse lethal dose (50 percent kill): >35200 µg/kgNIIRDN -,786,1990
skin/rabbit lethal dose (50 percent kill): >280 mg/kgNIIRDN -,786,1990
skin/rat lethal dose (50 percent kill): >29200 µg/kgNIIRDN -,786,1990
subcutaneous/cat lowest published lethal dose: 150 mg/kgLiver: Other changes

Kidney, Ureter, and Bladder: Other changes in urine composition

Blood: Normocytic anemia
AEPPAE 200,271,1942
subcutaneous/mouse lethal dose (50 percent kill): 110 mg/kgBehavioral: Somnolence (general depressed activity)YACHDS 13,3649,1985
subcutaneous/mouse lowest published toxic dose: 6359 µg/kgBiochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammationEJPHAZ 501,209,2004
subcutaneous/rabbit lowest published lethal dose: 400 mg/kgAEPPAE 200,271,1942
subcutaneous/rat lethal dose (50 percent kill): 94 mg/kgBehavioral: Somnolence (general depressed activity)YACHDS 13,3649,1985
subcutaneous/rat lowest published toxic dose: 10 mg/kgBiochemical: Neurotransmitters or modulators (putative): Catecholamine levels in CNSPYTOEY 18,788,2011
subcutaneous/rat lowest published toxic dose: 10 mg/kgBrain and Coverings: Other degenerative changesFTRPAE 109,52,2016
unreported route/mammal (species unspecified) lethal dose (50 percent kill): 230 mg/kgFRXXBL #2454807
unreported route/rat lowest published toxic dose: 9504 µg/kgVascular: BP lowering not characterized in autonomic sectionNSAPCC 375(Suppl 1),64,2007

Other Multiple Dose Data and References

Route/OrganismDoseEffectReference
implant/mouse lowest published toxic dose: 54506.4 ng/kg/4D- continuousCardiac: Other changes

Vascular: Relaxation (isolated tissue)

Biochemical: Metabolism (intermediary): Effect on mitochondrial function
NSAPCC 375(Suppl 1),107,2007
implant/rat lowest published toxic dose: 64 mg/kg/48H-continuousVascular: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
JPETAB 317,188,2006
inhalation/mammal (species unspecified) lowest published toxic concentration: 86 µg/m3/17W- intermittentBrain and Coverings: Other degenerative changes

Liver: Fatty liver degeneration

Cardiac: EKG changes not diagnostic of above
STGNBT -,180,1999
intraperitoneal/rat lowest published toxic dose: 825 mg/kg/33D- continuousKidney, Ureter, and Bladder: Other changes in urine composition

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
YACHDS 13,3689,1985
intraperitoneal/rat lowest published toxic dose: 1575 mg/kg/13W- intermittentEndocrine: Changes in adrenal weight

Nutritional and Gross Metabolic: Changes in: K

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
YACHDS 13,3753,1985
intraperitoneal/rat : 15 mg/kg/15D- intermittentBlood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases

Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
EJPHAZ 541,191,2006
intravenous/Dog lowest published toxic dose: 300 mg/kg/30D- intermittentLung, Thorax, or Respiration: Respiratory stimulation

Endocrine: Changes in thymus weight

Blood: Changes in platelet count
YACHDS 13,3753,1985
multiple/rat lowest published toxic dose: 64.3 mg/kg/48H- intermittentVascular: BP lowering not characterized in autonomic section

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
JPETAB 317,188,2006
oral/Dog lowest published toxic dose: 365 mg/kg/1Y- continuousBlood: Methemoglobinemia- Carboxhemoglobinemia

Blood: Changes in erythrocyte (RBC) count
HPV319 -,,2002
oral/human lowest published toxic dose: 0.6 mg/kg/14D- intermittentCardiac: Change in force of contraction

Cardiac: Change in rate

Vascular: Measurement of regional blood flow
FATOAO 49,84,1986
oral/mouse lowest published toxic dose: 70372 mg/kg/2Y- continuousBehavioral: Food intake (animal)

Blood: Methemoglobinemia- Carboxhemoglobinemia

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV319 -,,2002
oral/rabbit lowest published toxic dose: 30 mg/kg/26W- continuousCardiac: Cardiomyopathy including infarction

Cardiac: EKG changes not diagnostic of above

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
FATOAO 48,76,1985
oral/rabbit lowest published toxic dose: 4080 mg/kg/30D- intermittentCardiac: EKG changes not diagnostic of above

Cardiac: Pulse rate increased without fall in BP
FATOAO 48,76,1985
oral/rat lowest published toxic dose: 22.75 mg/kg/26W- continuousCardiac: Cardiomyopathy including infarction

Cardiac: EKG changes not diagnostic of above

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
FATOAO 48,76,1985
oral/rat lowest published toxic dose: 4080 mg/kg/30D- intermittentCardiac: EKG changes not diagnostic of above

Cardiac: Pulse rate increased without fall in BP

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
FATOAO 48,76,1985
oral/rat lowest published toxic dose: 22995 mg/kg/2Y- continuousBlood: Other changes

Blood: Changes in erythrocyte (RBC) count
HPV319 -,,2002
skin/rabbit lowest published toxic dose: 4900 mg/kg/5W- intermittentEndocrine: Changes in thymus weight

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Blood: Changes in leukocyte (WBC) count
KSRNAM 18,2794,1984
skin/rat lowest published toxic dose: 1500 mg/kg/30D- intermittentBlood: Pigmented or nucleated red blood cells

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
YACHDS 9,1477,1981
skin/rat lowest published toxic dose: 25480 mg/kg/26W- intermittentLiver: Other changes

Blood: Pigmented or nucleated red blood cells

Blood: Changes in platelet count
KSRNAM 18,2817,1984
skin/woman lowest published toxic dose: 32 mg/kg/20D- intermittentSkin: After topical application: Dermatitis, allergicCODEDG 45,299,2001
unreported route/rat lowest published toxic dose: 28512 µg/kg/3D- continuousBiochemical: Enzyme inhibition, induction, or change in blood or tissue levels: DehydrogenasesNSAPCC 375(Suppl 1),64,2007

Reviews

OrganizationStandardReference
American Conference of Governmental Industrial Hygienists (ACGIH)Threshold Limit Value-time-weighted average 0.05 ppm (skin)DTLVS* TLV/BEI,2013
TOXICOLOGY REVIEWNTIS** AD778-725
TOXICOLOGY REVIEWARPTDI 43,97,2003
TOXICOLOGY REVIEWMUREAV 488,151,2001
TOXICOLOGY REVIEWTPHSDY 23,401,2002
TOXICOLOGY REVIEWEMMUEG 43,143,2004
TOXICOLOGY REVIEWMUREAV 612,115,2006
TOXICOLOGY REVIEWBJPCBM 146,479,2005
TOXICOLOGY REVIEWMUREAV 584,1,2005
TOXICOLOGY REVIEWTOPADD 33,517,2005
TOXICOLOGY REVIEWHUTOX* -,395,1996
TOXICOLOGY REVIEWDERCL* 27,289,2009
TOXICOLOGY REVIEWNCLNA* 16,107,1998
TOXICOLOGY REVIEWMUREAV 750,1,2012
TOXICOLOGY REVIEWFCTOD7 55,596,2013

Standards and Regulations

OrganizationStandardReference
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV;
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV
Occupational Exposure Limit-ARAB Republic of Egypttime-weighted average 0.02 ppm (0.2 mg/m3), Skin, JAN1993
Occupational Exposure Limit-AUSTRALIAtime-weighted average 0.05 ppm (0.46 mg/m3), JUL2008
Occupational Exposure Limit-AUSTRIAMAK-TMW 0.05 ppm (0.5 mg/m3);KZW 0.2 ppm (2 mg/m3), skin, 2007
Occupational Exposure Limit-BELGIUMtime-weighted average 0.05 ppm (0.47 mg/m3), Skin, MAR2002
Occupational Exposure Limit-DENMARKceiling concentration 0.02 ppm (0.2 mg/m3), skin, MAY2011
Occupational Exposure Limit-FINLANDtime-weighted average 0.03 ppm (0.3 mg/m3), short term exposure limit 0.1 ppm (1 mg/m3), skin, NOV2011
Occupational Exposure Limit-FRANCEVME 0.1 ppm (1 mg/m3), Skin, FEB2006
Occupational Exposure Limit-GERMANYMAK 0.01 ppm (94 µg/m3), 2011
Occupational Exposure Limit-HUNGARYtime-weighted average 0.5 mg/m3, short term exposure limit 2 mg/m3, Skin, SEP2000
Occupational Exposure Limit-ICELANDshort term exposure limit 0.02 ppm (0.2 mg/m3), skin, NOV2011
Occupational Exposure Limit-JAPANceiling concentration 0.05 ppm (0.46 mg/m3), skin, MAY2012
Occupational Exposure Limit-KOREAtime-weighted average 0.05 ppm (0.5 mg/m3), skin, 2006
Occupational Exposure Limit-MEXICOtime-weighted average 0.05 ppm (0.5 mg/m3);short term exposure limit 0.1 ppm (1 mg/m3), 2004
Occupational Exposure Limit-NEW ZEALANDtime-weighted average 0.05 ppm (0.46 mg/m3), skin, JAN2002
Occupational Exposure Limit-NORWAYtime-weighted average 0.03 ppm (0.27 mg/m3), JAN1999
Occupational Exposure Limit-PERUtime-weighted average 0,05 ppm (0,46 mg/m3), JUL2005
Occupational Exposure Limit-POLANDMAC(time-weighted average) 0.5 mg/m3, MAC(short term exposure limit) 1 mg/m3, JAN1999
Occupational Exposure Limit-RUSSIAshort term exposure limit 0.02 mg/m3, Skin, JUN2003
Occupational Exposure Limit-SWEDENtime-weighted average 0.03 ppm (0.3 mg/m3);short term exposure limit 0.1 ppm (0.9 mg/m3), Skin, JUN2005
Occupational Exposure Limit-SWITZERLANDceiling concentration 0.01 ppm (0.094 mg/m3), skin, JAN2011
Occupational Exposure Limit-THAILANDtime-weighted average 0.2 ppm (2 mg/m3), JAN1993
Occupational Exposure Limit-THE NETHERLANDSMAC-TGG 0.5 mg/m3, Skin, 2003
Occupational Exposure Limit-THE PHILIPPINEStime-weighted average 0.2 ppm (2 mg/m3), Skin, JAN1993
Occupational Exposure Limit-TURKEYtime-weighted average 0.2 ppm (2 mg/m3), Skin, JAN1993
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)ceiling concentration 0.2 ppm (2 mg/m3) (skin)CFRGBR 29,1926.55,1994
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)ceiling concentration 0.2 ppm (2 mg/m3) (skin)CFRGBR 41,50-204.50,1994
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)ceiling concentration 0.2 ppm (2 mg/m3) (skin)CFRGBR 29,1910.1000,1994
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)ceiling concentration 0.2 ppm (2 mg/m3) (skin)CFRGBR 29,1915.1000,1993

NIOSH Documentation and Surveillance

OrganizationStandardReference
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO NITROGLYCERIN-airshort term exposure limit 0.1 mg/m3 (Sk)NIOSH* DHHS #92-100,1992
National Occupational Exposure Survey 1983Hazard Code 50890; Number of Industries 3; Total Number of Facilities 384; Number of Occupations 9; Total Number of Employees Exposed 38471; Total Number of Female Employees Exposed 29144
National Occupational Hazard Survey 1974Hazard Code 50890; Number of Industries 4; Total Number of Facilities 413; Number of Occupations 10; Total Number of Employees Exposed 4331

Status in Federal Agencies

OrganizationReference
EPA TSCA Section 8(b) CHEMICAL INVENTORY
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
NIOSH Analytical Method, 1994: Nitroglycerin, 2507
OSHA ANALYTICAL METHOD #43
TOP